Leukemia Research
Volume 27, Issue 5 , Pages 425-436 , May 2003

NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors

  • Ana I Benito

      Affiliations

    • Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, D1-100, P.O. Box 19024, Seattle, WA 98109-1204, USA
    • ,
  • Eileen Bryant

      Affiliations

    • Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, D1-100, P.O. Box 19024, Seattle, WA 98109-1204, USA
    • Department of Medicine, University of Washington, Seattle, WA, USA
    • ,
  • Michael R Loken

      Affiliations

    • Hematologics Inc., Seattle, WA, USA
    • ,
  • George E Sale

      Affiliations

    • Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, D1-100, P.O. Box 19024, Seattle, WA 98109-1204, USA
    • Department of Pathology, University of Washington, Seattle, WA, USA
    • ,
  • Richard A Nash

      Affiliations

    • Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, D1-100, P.O. Box 19024, Seattle, WA 98109-1204, USA
    • Department of Medicine, University of Washington, Seattle, WA, USA
    • ,
  • M John Gass

      Affiliations

    • Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, D1-100, P.O. Box 19024, Seattle, WA 98109-1204, USA
    • ,
  • H.Joachim Deeg

      Affiliations

    • Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, D1-100, P.O. Box 19024, Seattle, WA 98109-1204, USA
    • Department of Medicine, University of Washington, Seattle, WA, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-206-667-5985; fax: +1-206-667-6124.

Received 29 March 2002 ,Accepted 20 September 2002.

References 

  1. Mufti GJ. Chromosomal deletions in the myelodysplastic syndrome. Leuk. Res. 1992;16:35; [review]
  2. Raskind WH, Tirumali N, Singer J, Fialkow PJ. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood. 1984;63:1318
  3. Nowell PC. Chromosome abnormalities in myelodysplastic syndromes. Semin. Oncol. 1992;19:25; [review]
  4. Parlier V, van Melle G, Beris P, Schmidt PM, Tobler A, Haller E, et al.  Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings. Cancer Genet. Cytogenet. 1994;78:219
  5. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes [published erratum appears in Blood 1998;91:1100]. Blood. 1997;89:2079
  6. Suciu S, Kuse R, Weh HJ, Hossfeld DK. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome. Cancer Genet. Cytogenet. 1990;44:15
  7. Gersuk GM, Beckham C, Loken MR, Kiener P, Anderson JE, Farrand A, et al.  A role for tumor necrosis factor-α, Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome. Br. J. Haematol. 1998;103:176
  8. Bernell P, Jacobsson B, Nordgren A, Hast R. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology. Leukemia. 1996;10:662
  9. Weimar IS, Bourhis JH, de Gast GC, Gerritsen WR. Clonality in myelodysplastic syndromes. Leuk. Lymphoma. 1994;13:215; [review]
  10. Asano H, Ohashi H, Ichihara M, Kinoshita T, Murate T, Kobayashi M, et al.  Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes. Blood. 1994;84:588
  11. Janssen JWG, Buschle M, Layton M, Drexler HG, Lyons J, Van Den Berghe H, et al.  Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood. 1989;73:248
  12. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al.  The French–American–British (FAB) co-operative group. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982;51:189
  13. Noel P, Solberg LA. Myelodysplastic syndromes. Pathogenesis, diagnosis and treatment. Crit. Rev. Oncol. Haematol. 1992;12:193
  14. Lowenthal RM, Marsden KA. Myelodysplastic syndromes. Int. J. Haematol. 1997;65:319; [review]
  15. Shetty V, Mundle S, Alvi S, Showel M, Broady-Robinson L, Dar S, et al.  Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk. Res. 1996;20:891
  16. Shetty V, Hussaini S, Broady-Robinson L, Allampallam K, Mundle S, Borok R, et al.  Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates. Blood. 2000;96:1388
  17. Yoshida Y, Mufti GJ. Apoptosis and its significance in MDS: controversies revisited. Leuk. Res. 1999;23:777; [review]
  18. Parker JE, Mufti GJ, Rasool F, Mijovic A, Devereux S, Pagliuca A. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood. 2000;96:3932
  19. Oyake T, Ishida Y, Ito S, Utsugisawa T, Murai K, Kuriya S-I. Leukemic progression in myelodysplastic syndrome is associated with the decreased frequency of excessive apoptosis in blast cells. Blood 2000;96(Suppl 1):359a, 1548 [abstract].
  20. Jacobs A. Genetic abnormalities in myelodysplastic syndrome. Cancer Genet. Cytogenet. 1991;56:1; [review]
  21. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988;241:1632
  22. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, et al.  Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 1995;154:180
  23. Pflumio F, Izac B, Katz A, Shultz LD, Vainchenker W, Coulombel L. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood. 1996;88:3731
  24. Cashman JD, Lapidot T, Wang JCY, Doedens M, Shultz LD, Lansdorp P, et al.  Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood. 1997;89:4307
  25. Lapidot T, Fajerman Y, Kollet O. Immune-deficient SCID and NOD/SCID mice models as functional assays for studying normal and malignant human hematopoiesis. J. Mol. Med. 1997;75:664; [review]
  26. Ailles LE, Gerhard B, Kawagoe H, Hogge DE. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice. Blood. 1999;94:1761
  27. Larochelle A, Vormoor J, Hanenberg H, Wang JC, Bhatia M, Lapidot T, et al.  Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat. Med. 1996;2:1329
  28. Bhatia M, Wang JCY, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 1997;94:5320
  29. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997;3:730
  30. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc. Natl. Acad. Sci. U.S.A. 1986;83:2934
  31. Busque L, Gilliland DG. The PGK-PCR clonality assay (PPCA). Mol. Biotechnol. 1996;5:275
  32. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of Hpa II and Hha I sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am. J. Hum. Genet. 1992;51:1229
  33. Thanopoulou E, Cashman J, Zoumbos N, Eaves A, Eaves C. Evidence of early transient engraftment of NOD/SCID-β2 microglobulin null mice with neoplastic cells from myelodysplastic syndrome patients. Blood 2000;96(Suppl 1):835a, 3606 [abstract].
  34. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science. 1992;255:1137
  35. Garcia S, Dadaglio G, Gougeon ML. Limits of the human-PBL-SCID mice model: severe restriction of the V beta T-cell repertoire of engrafted human T cells. Blood. 1997;89:329
  36. Leung W, Ramirez M, Novelli EM, Civin CI. In vivo engraftment potential of clinical hematopoietic grafts. J. Invest. Med. 1998;46:303
  37. White NJ, Nacheva E, Asimakopoulos FA, Bloxham D, Paul B, Green AR. Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells. Blood. 1994;83:2809
  38. Nilsson L, Astrand-Grundstrom I, Arvidsson I, Jacobsson B, Hellstrom-Lindberg E, Hast R, et al.  Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood. 2000;96:2012
  39. Gerritsen WR, Donohue J, Bauman J, Jhanwar SC, Kernan NA, Castro-Malaspina H, et al.  Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization. Blood. 1992;80:217
  40. Kroef MJ, Bolk MJ, Muus P, Wessels JW, Beverstock GC, Willemze R, et al.  Mosaicism of the 5q deletion as assessed by interphase FISH is a common phenomenon in MDS and restricted to myeloid cells. Leukemia. 1997;11:519
  41. Nilsson L, Åstrand-Grundström I, Anderson K, Arvidsson I, Hokland P, Kjeldsen L, et al. Involvement and intrinsic deficiencies of hematopoietic stem cells in MDS patients with trisomy 8. Blood 2001;98(1):354a, 1491 [abstract].
  42. Novelli EM, Ramirez M, Civin CI. Biology of CD34+CD38− cells in lymphohematopoiesis. Leuk. Lymphoma. 1998;31:285; [review]
  43. Terstappen LWMM, Huang S, Safford M, Lansdorp PM, Loken MR. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38− progenitor cells. Blood. 1991;77:1218
  44. Culligan DJ, Cachia P, Whittaker J, Jacobs A, Padua RA. Clonal lymphocytes are detectable in only some cases of MDS. Br. J. Haematol. 1992;81:346
  45. Nakamura R, Epperson DE, Saunthararajah Y, Melenhorst JJ, Barrett AJ. Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process. Blood 2000;96(Suppl 1):355a, 1534 [abstract].
  46. Ramirez M, Rottman GA, Shultz LD, Civin CI. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras. Exp. Haematol. 1998;26:332
  47. Fujiki Y, Onodera M, Yamaguchi T, Osawa M, Sudo K, Hamada H, et al.  Dominant expansion of human T cells in non-obese diabetic/severe combined immunodeficiency mice implanted with human bone fragments. Exp. Haematol. 2000;28:792
  48. Molldrem JJ, Jiang YZ, Stetler-Stevenson M, Mavroudis D, Hensel N, Barrett AJ. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor V beta profiles. Br. J. Haematol. 1998;102:1314
  49. Bogdanovic AD, Jankovic GM, Colovic MD, Trpinac DP, Bumbasirevic VZ. Apoptosis in bone marrow of myelodysplastic syndrome patients. Blood. 1996;87:3064; [letter]
  50. Deeg HJ. Marrow stroma in MDS: culprit or bystander?. Leuk. Res. 2002;26:687
  51. Awaya N, Rupert K, Bryant E, Torok-Storb B. Marrow stromal cells are not derived from the malignant clone in myelodysplastic syndromes (MDS). Blood 2001;98(1):353a, 1487 [abstract].
  52. Christianson SW, Greiner DL, Hesselton RA, Leif JH, Wagar EJ, Schweitzer IB, et al.  Enhanced human CD4+ T cell engraftment in beta 2-microglobulin-deficient NOD-scid mice. J. Immunol. 1997;158:3578
  53. Glimm H, Eisterer W, Lee K, Cashman J, Holyoake TL, Nicolini F, et al.  Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-β2 microglobulin-null mice. J. Clin. Invest. 2001;107:199
  54. Thanopoulou E, Eaves A, Eaves C, Zoumbos N. Neoplastic cells from patients with myelodysplastic syndrome (MDS) consistently engraft NOD/SCID β2 microglobulin null mice. Blood 2001;98(1):729a, 3042 [abstract].

PII: S0145-2126(02)00221-7

doi: 10.1016/S0145-2126(02)00221-7

Leukemia Research
Volume 27, Issue 5 , Pages 425-436 , May 2003

Article Tools

* Image Usage & Resolution